Introduction
Human U-937 and HL-60 myeloid leukemia cell lines proliferate autonomously in the absence of exogenous hematopoietic growth factors (Collins, 1987; Sundstrom and Nilsson, 1976) . These cells have also retained the capacity to respond to inducers of dierentiation with appearance of a mature phenotype. For example, treatment of U-937 cells with agents that activate protein kinase C (PKC), including 12-Otetradecanoylphorbol-13-acetate (TPA) and phorbol-12, 13-dibutyrate (PDBu), induces dierentiation along the monocytic lineage. Other structurally unrelated agents such as the macrocytic lactone bryostatin-1, teleocidin and phospholipase C also activate PKC and induce monocytic dierentiation of myeloid leukemia cells (Fujiki et al., 1984; Stone et al., 1988a,b) . These ®ndings and the demonstration that TPA treatment is associated with growth arrest have indicated that factor-independent growth of myeloid leukemia cells is reversible by activation of PKC-mediated signaling. Little is known, however, about the downstream eectors responsible for induction of the dierentiated monocytic phenotype.
The PKC family of serine/threonine protein kinases consists of at least 12 isoforms which are involved in diverse cellular processes (Jaken, 1996; Nishizuka, 1988) . The ®ndings that TPA-resistant HL-60 cell variants are de®cient in PKCb expression have supported a role for this isoform in dierentiation of myeloid leukemia cells (MacFarlane and Manzel, 1994; Nishikawa et al., 1990; Tonetti et al., 1992 Tonetti et al., , 1994 . In addition, down-regulation of PKCb expression and functional defects in PKCb (Kiley et al., 1997) have been identi®ed in TPA-resistant U-937 cells. Defective translocation of PKCb from the cytosol to the cell membrane has also been shown for TPAresistant variants of both U-937 and HL-60 cells Yang et al., 1994) . Induction of PKCb expression with retinoic acid (Yang et al., 1994) or transfection of the PKCb gene (Tonetti et al., 1994) restores sensitivity of the resistant variants to TPAinduced monocytic dierentiation. These ®ndings have collectively established an essential role for PKCb in TPA-induced monocytic dierentiation of myeloid leukemia cells.
Other studies have shown that TPA-induced monocytic dierentiation of myeloid leukemia cells is associated with endonucleolytic DNA fragmentation . These ®ndings and the demonstration that TPA induces terminal dierentiation have suggested that apoptosis is associated with appearance of the dierentiated phenotype. The results of the present studies demonstrate that TPA induces the release of mitochondrial cytochrome c and activation of caspase-3 by a PKCb-dependent mechanism. The results also provide support for a model in which TPA-induced monocytic dierentiation is dependent on caspase-mediated signaling.
Results
To determine whether dierentiation of human myeloid leukemia cells is associated with induction of apoptosis, we assessed the eects of TPA on U-937 cells and the PKCb-de®cient TUR variant. TPA treatment of U-937 cells was associated with the expression of a dierentiated phenotype by 90% of cells as assessed by adherence and increases in NSE staining (Table 1 ). In addition, the adherent and nonadherent cells were separated and analysed by NSE staining. The results demonstrate that, in contrast to non-adherent cells, positive NSE staining was observed only in adherent (dierentiated) cells. As shown previously , treatment of U-937 cells with TPA also resulted in oligonucleosomal DNA fragmentation ( Figure 1a ). By contrast, TUR cells failed to respond to TPA with induction of the dierentiated phenotype (Table 1) or DNA fragmentation ( Figure 1a ). To con®rm that PKCb is required for induction of both the dierentiated monocytic phenotype and DNA fragmentation, we performed similar studies on TUR cells transfected to stably express the empty neo vector or PKCb (Kaneki et al., 1999) . The TUR/PKCb, and not the TUR/neo, cells responded to TPA with induction of monocytic dierentiation (Table  1) and DNA cleavage (Figure 1b) . To quantitate the induction of apoptosis, the cells were stained with DAPI after TPA treatment and assayed for the percentage of apoptotic cells with nuclear fragmentation and chromatin condensation. The results demonstrate that treatment of TUR/PKCbII cells with TPA is associated with over 20% apoptosis, while less than 10% of the TPA-treated TUR cells were apoptotic ( Figure 1c ). These ®ndings suggest that TPA-induced monocytic dierentiation of U-937 cells is associated with induction of apoptosis by a PKCb-dependent mechanism.
Treatment of U-937 cells with the DNA-damaging agent 1-b-D-arabinofuranosylcytosine (ara-C) is associated with cytochrome c-dependent induction of apoptosis . To de®ne in part the signals responsible for TPA-induced apoptosis, we assessed the release of cytochrome c from mitochondria to the cytosol. Immunoblot analysis of cytosolic preparations with anti-cytochrome c demonstrated release in TPA-treated U-937 (Figure 2a ), but not in TPA-treated TUR, cells (Figure 2b ). TPA-treated TUR/PKCb, and not TUR/neo, cells also responded to TPA with release of cytochrome c (Figure 2b ). Cytochrome c induces a cascade that results in cleavage and thereby activation of the executioner caspase-3 (Kharbanda et al., 1997; Liu et al., 1996) . In concert with the ®nding of cytochrome c release, TPA treatment of U-937 cells, like that obtained with ara-C, resulted in cleavage of caspase-3 ( Figure 2c ). By contrast, while ara-C induced cleavage of caspase-3 in TUR cells, TPA had no detectable eect ( Figure 2c ). In addition, whereas there was no apparent activation of caspase-3 in TPA-treated TUR/neo cells, TUR/PKCb cells responded to TPA with caspase-3 cleavage ( Figure  2d ). These results indicate that TPA-induced apoptosis is mediated by a PKCb-dependent mechanism involving cytochrome c release and activation of caspase-3.
To determine whether caspase activation is linked to TPA-induced apoptosis and dierentiation, we treated U-937 cells with the caspase inhibitor Z-VAD-fmk Cells were seeded onto six-well tissue culture dishes (2610 5 cells/well) and cultured in the presence and absence of 50 nM TPA for 24 h. Adherence to the culture dish and NSE staining (Kaneki et al., 1999) are expressed as the mean of three determinations and normalized to their respective controls (standard error, 510%) (Xiang et al., 1996) . The results demonstrate that Z-VAD-fmk inhibits TPA-induced DNA fragmentation of U-937 cells (Figure 3a) . Similar eects of Z-VADfmk were observed with TPA-treated TUR/PKCb cells (data not shown). Z-VAD-fmk also blocked TPAinduced cytochrome c release ( Figure 3b ) and caspase-3 activation (Figure 3c ). These results indicated that TPA activates a caspase upstream to the release of cytochrome c and cleavage of caspase-3. Moreover, the ®nding that Z-VAD-fmk blocks TPA-induced adherence and NSE staining (Table 1) indicates that caspase activation is involved in appearance of the dierentiated phenotype. These ®ndings provided support for the involvement of a caspase upstream to caspase-3 in TPA-induced dierentiation.
The cowpox virus CrmA protein inhibits ICE/ caspase-1-like proteases and not caspase-3 (Fraser and Evan, 1996) . U-937 cells that stably overexpress CrmA (Datta et al., 1997) were therefore treated with TPA and studied for induction of dierentiation, growth arrest and apoptosis. The results demonstrate that CrmA expression blocks TPA-induced adherence and NSE staining (Table 1) . These ®ndings demonstrate that activation of a caspase-1-like protease is necessary for TPA-induced monocytic dierentiation.
In studies of TPA-induced growth arrest, there were no signi®cant dierences between TPA-treated wildtype U-937 or U-937/CrmA cells. In addition, cell cycle analysis demonstrated no signi®cant dierence in cell cycle distribution following TPA treatment of U-937 or U-937/CrmA cells (data not shown). Signi®cantly, the results from cell survival assays, however, demonstrated that exposure of U-937/CrmA cells to TPA is associated with increased survival (91+6.5% at 48 h) as compared to that obtained with TPA-treated U-937 cells (79+4.0). In concert with these ®ndings, U-937/ CrmA cells were also resistant to TPA-induced DNA fragmentation (Figure 4a ). The results of DAPI staining further demonstrate that treatment of U-937 cells with TPA is associated with 21% of cells exhibiting nuclear fragmentation and chromatin condensation (Figure 4b ). By contrast, treatment of U-937/CrmA cells with TPA was associated with less than 9% of apoptotic cells (Figure 4b ). These ®ndings demonstrate that TPA-induced dierentiation and apoptosis of U-937 cells are both mediated by an ICE/caspase-1-like protease.
To assess the involvement of caspase-1 in TPAinduced dierentiation and apoptosis, lysates from TPA-treated U-937 and U-937/CrmA cells were analysed for cleavage of caspase-1 by immunoblotting with a caspase-1 antibody. The results demonstrate no detectable cleavage of caspase-1 in the response of U-937 or U-937/CrmA cells to TPA (data not shown). Notably, however, CrmA expression blocked TPAinduced cytochrome c release (Figure 5a ) and caspase-3 activation (Figure 5b ). These ®ndings, like those with the peptide inhibitors, provide support for a model in 
Discussion
Recent work has shown that TPA induces the interaction of PKCb with MEK kinase 1 (MEKK-1), an upstream eector of the SEK1?stress-activated protein kinase (SAPK) cascade (Kaneki et al., 1999) . SAPK phosphorylates and activates the c-Jun, ATF2 and ELK1 transcription factors (Gupta et al., 1995; Raingeaud et al., 1996; Whitmarsh et al., 1995) . As TPA-induced monocytic dierentiation is associated with induction of c-Jun Szabo et al., 1994; William et al., 1990) and EGR-1 (Kharbanda et al., 1990 gene expression, SAPK-mediated activation of c-Jun, ATF2 and ELK-1 and thereby early response genes is associated with appearance of the dierentiated phenotype. These ®ndings have thus supported a model in which PKCb activation is necessary for activation of the MEKK-1?SEK-1?SAPK pathway and early response genes in the TPA response of myeloid leukemia cells.
The present ®ndings extend the role of PKCb as an eector of the apoptotic response of myeloid leukemia cells to TPA. The results demonstrate that TPA induces apoptosis of U-937 cells by a mechanism involving the release of mitochondrial cytochrome c and the activation of caspase-3. Signi®cantly, cells de®cient in PKCb fail to respond to TPA with cytochrome c release, caspase-3 activation and induction of apoptosis. Moreover, reconstitution of PKCb expression restores TPA-induced apoptotic signaling. These ®ndings support the involvement of PKCb activation as a signal upstream to the release of mitochondrial cytochrome c and the induction of apoptosis. Previous studies have demonstrated that cytochrome c is released in the response of cells to genotoxic agents, growth factor withdrawal and Figure 3 Caspase inhibitor Z-VAD-fmk blocks TPA-induced DNA fragmentation, cytochrome c release and activation of caspase-3. U-937 cells were treated with 50 nM TPA and/or 10 mM Z-VAD-fmk for 24 h. (a) DNA fragmentation was assessed by electrophoresis in agarose gels. (b) Cytosolic lysates were subjected to 15% SDS ± PAGE and immunoblot analysis with anticytochrome c and anti-actin. (c) Total cell lysates were analysed by 12.5% SDS ± PAGE and immunoblotting with anti-caspase-3 engagement of the tumor necrosis factor and Fas receptors (Bossy-Wetzel et al., 1998; Kharbanda et al., 1997; Kluck et al., 1997; Liu et al., 1996; Yang et al., 1997) . The present studies, however, provide the ®rst evidence for involvement of a PKC isoform in regulating cytochrome c-dependent apoptosis. The regulation of apoptosis in response to phorbol esters is complex and may be mediated by dierent isoforms of PKC. In this context, other studies have shown that dysregulated expression of PKCz potentiates TPAinduced apoptosis (de Vente et al., 1995) .
The present ®ndings provide further support for involvement of caspase-dependent signaling in the induction of monocytic dierentiation. Treatment of U-937 cells with Z-VAD-fmk inhibited both TPAinduced apoptosis and the induction of dierentiation. Similar results were obtained in TPA-treated cells that overexpress the caspase inhibitor CrmA. The ®nding that these caspase inhibitors also block TPA-induced cytochrome c release supports a model in which activation of a caspase-1-like protease regulates both mitochondrial signaling and induction of the dierentiated phenotype. Taken together with the demonstration that PKCb is required for TPA-induced cytochrome c release, the results suggest that PKCb functions upstream to a pathway involving caspase activation and thereby release of cytochrome c ( Figure  5b ). Caspase-8 has been shown to function as an upstream eector of cytochrome c release (Luo et al., 1998) ; however, TPA had no detectable eect on proteolytic cleavage of procaspase-1 or pro-caspase-8 (data not shown). Thus, a CrmA-sensitive, caspase-1-like protease other than caspase-1 or caspase-8 appears to confer PKCb-dependent induction of apoptosis and dierentiation. In summary, TPA treatment of human myeloid leukemia cells is associated with the induction of terminal monocytic dierentiation. The present work demonstrates that appearance of the dierentiated monocytic phenotype and the induction of apoptosis are regulated at least in part by a common signaling cascade that involves PKCb and caspase activation. Dependence of dierentiation induction on cell death pathways could provide a mechanism for the turnover of cells that have undergone maturation and completion of their functional role.
Materials and methods

Cell culture and reagents
Human U-937 myeloid cells (American Type Culture Collection, Rockville, MD, USA) and TUR cells were grown in RPMI 1640 medium (Cellgrow) supplemented with 10% heat-inactivated fetal bovine serum (Sigma), 100 units/ml penicillin, 100 mg/ml streptomycin and 2 mM L-glutamine. U-937/CrmA cells (Datta et al., 1997) , TUR/neo and TUR/PKCb (Kaneki et al., 1999) were cultured in the same medium containing 500 mg/ml geneticin sulfate (GIBCO/BRL). The cells were suspended at 2.5610 5 / ml and treated with 50 nM TPA (Sigma).
Nonspecific esterase staining
Cells were treated with 50 nM TPA for various times. Cytocentrifuge smears of cultured cells were prepared and examined for nonspeci®c esterase (NSE) staining as described (Yam et al., 1971 ).
Preparation of cell lysates
Cells were washed with phosphate buered saline (PBS) and lysed in lysis buer (Kharbanda et al., 1995) containing 1% NP-40. Cytosolic lysates were prepared as described (Kharbanda et al., 1997) . In brief, cells were harvested by centrifugation at 1800 g for 10 min at 48C. After washing with cold PBS, the cell pellet was suspended in 5 vol of buer A (20 mM HEPES, pH 7.5, 10 mM KCl, 1.5 mM MgCl 2 , 1 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol, 0.1 mM PMSF, 10 mg/ml aprotinin, 10 mg/ml leupeptin and 250 mM sucrose). After incubation on ice for 15 min, the cells were disrupted in a Dounce homogenizer. Following centrifugation for 5 min at 1000 g at 48C, the supernatants were centrifuged at 105 000 g for 30 min at 48C. The resulting supernatant was used as the cytosolic fraction.
Immunoblot analysis
Proteins were separated in 12.5 or 15% SDS-polyacrylamide gels and then transferred to nitrocellulose ®lters. After blocking with 5% dried milk in PBST (PBS/0.05% Tween 20), the ®lters were incubated with anti-cytochrome c (Kirken et al., 1995) , anti-caspase-3 (anti-CPP32; Transduction Laboratories), anti-caspase-1 (Santa Cruz), anti-caspase-8 (Santa Cruz) or anti-actin antibodies. Following washing and incubation with horseradish peroxidase-conjugated antirabbit or anti-mouse (Amersham) antibodies, the antigenantibody complexes were analysed by ECL reagent (Amersham).
Analysis of DNA fragmentation
Cells (1610 6 ) were washed with PBS, lysed in buer containing 10 mM Tris-HCl, pH 8.0, 10 mM EDTA, 0.5% Triton X-100 and incubated with 0.5% SDS and 25 mg/ml RNase (Boehringer-Mannheim) at 378C for 1 h. Proteinase K (100 mg/ml; Sigma) was then added and the mixture incubated overnight at 378C. After extraction with phenol/ chloroform and precipitation in ethanol, the DNA was resuspended in TE buer (10 mM Tris-HCl, pH 8.0, 1 mM EDTA). The samples were then subjected to electrophoresis in a 1.5% agarose gel and visualized by UV illumination after ethidium bromide staining.
Quantitative analysis of apoptosis
Cells were harvested and ®xed with 4% paraformaldehyde in PBS (pH 7.4) at room temperature. The cells were then permeabilized with 0.1% Triton X-100 and stained with 0.5 mg 4',6-diamidino-2-phenylindole (DAPI)/ml for 10 min at room temperature. Apoptosis was assessed by microscopic detection of nuclear fragmentation and chromatin condensation.
Abbreviations PKC, protein kinase C; TPA, 12-O-tetradecanoylphorbol-13-acetate; Bid, Bcl-2 interacting protein; cyt c, cytochrome c.
